Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

Anticoagulants

  • Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation
    You have accessRestricted Access
    Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation
    Thomas A. Mavrakanas, Katherine Garlo and David M. Charytan
    CJASN August 2020, 15 (8) 1146-1154; DOI: https://doi.org/10.2215/CJN.11650919
    Add to Selected Citations
  • IgA Nephropathy in Elderly Patients
    You have accessRestricted Access
    IgA Nephropathy in Elderly Patients
    Angel M. Sevillano, Monserrat Diaz, Fernando Caravaca-Fontán, Clara Barrios, Carmen Bernis, Jimena Cabrera, Jesus Calviño, Lorena Castillo, Carmen Cobelo, Patricia Delgado-Mallén, Mario Espinosa, Gema Fernandez-Juarez, Maria Jose Fernandez-Reyes, Rosa Garcia-Osuna, Patricia Garcia, Marian Goicoechea, Fayna Gonzalez-Cabrera, Diomaris A. Guzmán, Manuel Heras, Guillermo Martín-Reyes, Alberto Martinez, Teresa Olea, Jessy Korina Peña, Luis F. Quintana, Cristina Rabasco, Katia López Revuelta, Lida Rodas, Nuria Rodriguez-Mendiola, Eva Rodriguez, Luz San Miguel, Maria Dolores Sanchez de la Nieta, Amir Shabaka, Milagros Sierra, Alfonso Valera, Mercedes Velo, Eduardo Verde, Jose Ballarin, Oscar Noboa, Juan Antonio Moreno, Eduardo Gutiérrez, Manuel Praga and on behalf of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)
    CJASN August 2019, 14 (8) 1183-1192; DOI: https://doi.org/10.2215/CJN.13251118
    Add to Selected Citations
  • Open Access
    Anticoagulant-Related Nephropathy
    Richard J. Glassock
    CJASN June 2019, 14 (6) 935-937; DOI: https://doi.org/10.2215/CJN.02470319
    Add to Selected Citations
  • You have accessRestricted Access
    Correction
    CJASN May 2019, 14 (5) 750; DOI: https://doi.org/10.2215/CJN.02630319
    Add to Selected Citations
  • Open Access
    Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease
    Nishank Jain and Robert F. Reilly
    CJASN February 2019, 14 (2) 278-287; DOI: https://doi.org/10.2215/CJN.02170218
    Add to Selected Citations
  • Open Access
    Clinical Pharmacogenomics
    Solomon M. Adams, Karryn R. Crisamore and Philip E. Empey
    CJASN October 2018, 13 (10) 1561-1571; DOI: https://doi.org/10.2215/CJN.02730218
    Add to Selected Citations
  • Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
    You have accessRestricted Access
    Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
    Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
    CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217
    Add to Selected Citations
  • You have accessRestricted Access
    Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction
    Paul M. Palevsky
    CJASN November 2016, 11 (11) 2078; DOI: https://doi.org/10.2215/CJN.09700916
    Add to Selected Citations
  • You have accessRestricted Access
    Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro
    Peter A. McCullough, Timothy Ball, Katy Mathews Cox and Manish D. Assar
    CJASN November 2016, 11 (11) 2079-2084; DOI: https://doi.org/10.2215/CJN.02680316
    Add to Selected Citations
  • You have accessRestricted Access
    Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1
    Nisha Bansal
    CJASN November 2016, 11 (11) 2093-2094; DOI: https://doi.org/10.2215/CJN.08610816
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire